Home > PE Ratio > CIPLA

CIPLA
PE (Price/Earnings) Ratio

The Current P/E Ratio of CIPLA is 22.98.

Share Price ₹1,505.3Jun 30,2025
Market Cap ₹121,598.1 Cr
Earnings-TTM₹5,291.1 CrTTM-Consolidated Results
Price/Earnings22.98xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals

Definition & Calculation of PE (Price/Earnings) ratio of CIPLA

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of CIPLA is calculated as :

Current Market Cap [ ₹121,598.1 Cr] as on Jun 30,2025

(/) Earnings [ ₹5,291.1 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 22.98x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for CIPLA , the investors are currently willing to pay 22.98 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of CIPLA !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of CIPLA over the last five years.

Historical PE (Price/Earnings) ratio chart of CIPLA


PE Ratio Performance Analysis for CIPLA

- CIPLA 's latest p/e ratio is 22.98x.

- CIPLA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 27.46x.

- CIPLA 's operated at median p/e ratio of 27.34x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, CIPLA 's p/e ratio peaked in Mar2022 at 32.65x.

- CIPLA 's p/e ratio hit its five-year low in Mar2025 of 22.08x.


How does CIPLA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
CIPLA 5,291.0522.98121,598.1
SUN PHARMACEUTICAL INDUSTRIES LTD10,980.1036.64402,320.0
DIVIS LABORATORIES LTD2,191.0082.53180,823.0
TORRENT PHARMACEUTICALS LTD1,911.0060.39115,400.0
DR REDDYS LABORATORIES LTD5,703.5018.78107,135.0
MANKIND PHARMA LTD2,003.2247.8695,868.6
ZYDUS LIFESCIENCES LTD4,614.8021.5899,576.9
LUPIN LTD3,306.2626.7788,502.5
AUROBINDO PHARMA LTD3,515.2618.7565,926.8
ABBOTT INDIA LTD1,414.4453.5475,727.1
ALKEM LABORATORIES LTD2,216.0026.6459,029.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs CIPLA 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.75x
Max industry PE 82.53x
Median industry PE 26.77x
Average industry PE 37.86x



You may also like the below Video Courses